CorMedix Inc. (CRMD)

CorMedix Statistics

Total Valuation

CorMedix has a market cap or net worth of $757.86 million. The enterprise value is $712.38 million.

Market Cap	757.86M
Enterprise Value	712.38M

Important Dates

The next estimated earnings date is Tuesday, March 11, 2025, before market open.

Earnings Date	Mar 11, 2025
Ex-Dividend Date	n/a

Share Statistics

CorMedix has 60.68 million shares outstanding. The number of shares has increased by 23.09% in one year.

Current Share Class	60.68M
Shares Outstanding	60.68M
Shares Change (YoY)	+23.09%
Shares Change (QoQ)	+2.09%
Owned by Insiders (%)	1.07%
Owned by Institutions (%)	32.00%
Float	60.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	21.11
PS Ratio	58.93
Forward PS	5.45
PB Ratio	12.31
P/TBV Ratio	13.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	58.10
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.96, with a Debt / Equity ratio of 0.01.

Current Ratio	3.96
Quick Ratio	3.43
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,546.43

Financial Efficiency

Return on equity (ROE) is -65.04% and return on invested capital (ROIC) is -44.49%.

Return on Equity (ROE)	-65.04%
Return on Assets (ROA)	-37.69%
Return on Capital (ROIC)	-44.49%
Revenue Per Employee	$147,738
Profits Per Employee	-$556,005
Employee Count	83
Asset Turnover	0.15
Inventory Turnover	n/a

Taxes

Income Tax	-1.39M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +283.13% in the last 52 weeks. The beta is 1.56, so CorMedix's price volatility has been higher than the market average.

Beta (5Y)	1.56
52-Week Price Change	+283.13%
50-Day Moving Average	9.92
200-Day Moving Average	7.11
Relative Strength Index (RSI)	70.88
Average Volume (20 Days)	1,354,332

Short Selling Information

The latest short interest is 7.00 million, so 11.54% of the outstanding shares have been sold short.

Short Interest	7.00M
Short Previous Month	6.73M
Short % of Shares Out	11.54%
Short % of Float	11.67%
Short Ratio (days to cover)	7.94

Income Statement

In the last 12 months, CorMedix had revenue of $12.26 million and -$46.15 million in losses. Loss per share was -$0.80.

Revenue	12.26M
Gross Profit	10.25M
Operating Income	-50.96M
Pretax Income	-51.63M
Net Income	-46.15M
EBITDA	-50.77M
EBIT	-50.96M
Loss Per Share	-$0.80

Balance Sheet

The company has $46.03 million in cash and $556,416 in debt, giving a net cash position of $45.47 million or $0.75 per share.

Cash & Cash Equivalents	46.03M
Total Debt	556,416
Net Cash	45.47M
Net Cash Per Share	$0.75
Equity (Book Value)	58.71M
Book Value Per Share	1.01
Working Capital	54.67M

Cash Flow

In the last 12 months, operating cash flow was -$55.75 million and capital expenditures -$401,792, giving a free cash flow of -$56.15 million.

Operating Cash Flow	-55.75M
Capital Expenditures	-401,792
Free Cash Flow	-56.15M
FCF Per Share	-$0.93

Margins

Gross Margin	83.57%
Operating Margin	-415.59%
Pretax Margin	-387.72%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CorMedix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.09%
Shareholder Yield	-23.09%
Earnings Yield	-6.09%
FCF Yield	-7.41%

Analyst Forecast

The average price target for CorMedix is $15.67, which is 25.46% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.67
Price Target Difference	25.46%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on March 26, 2019. It was a reverse split with a ratio of 0.2:1.

Last Split Date	Mar 26, 2019
Split Type	Reverse
Split Ratio	0.2:1

Scores

CorMedix has an Altman Z-Score of 0.1 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.1
Piotroski F-Score	1